Biotech Equity Capital Markets Monthly
The Biotech Equity Capital Markets Monthly highlights current macroeconomic conditions, recent equity performance, notable industry news and financing trends in the sector.
Baird is a leading advisor and equity underwriter to companies across the globe. Our integrated team provides clients with deep sector knowledge, process expertise, geographic reach and relationships with key industry participants and investors.
For more information about Baird’s coverage, visit out Biotechnology & Pharmaceuticals page.
